General Information
Version
CLP_F
Revision date
2022-06-02
Product name
NEODECANOYL CHLORIDE
CAS No.
40292-82-8
REACH No
01-2119473976-19-0002;
Emergency telephone
06 80 201 199
Icons in SDS
Company Information
company name
Framochem French-Hungarian Fine Chemicals Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@framochem.hu
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H302, H314, H330
Hazard statements
Code
Statements
H302
Harmful if swallowed
H314
Causes severe skin burns and eye damage.
H330
Fatal if inhaled
Section 2
SECTION 2: Hazards identification
CLP CLASSIFICATION
Acute toxicity (oral), Hazard Category 4 – H302 Skin corrosion/irritation, Hazard Category 1B – H314 Acute toxicity (inhalation), Hazard Category 2 – H330 Warning H statements: H302 – Harmful if swallowed. H314 – Causes severe skin burns and eye damage. H330 – Fatal if inhaled.
2.2 Label elements
IUPAC name: Neodecanoyl chloride CAS number: 40292-82-8 EC number: 254-875-0 DANGER Warning H statements: H302 – Harmful if swallowed. H314 – Causes severe skin burns and eye damage. H330 – Fatal if inhaled.
Precautionary statements
P260 – Do not breathe dust/fume/gas/mist/vapours/spray. P280 – Wear protective gloves/protective clothing/eye protection/face protection. P284 – Wear respiratory protection. P301+P330+P331 – IF SWALLOWED: rinse mouth. Do NOT induce vomiting. P303 + P361 + P353 – IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. P304+P340 – IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338 – IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing: Continue rinsing. P310 – Immediately call a POISON CENTER or doctor/physician. P405 – Store locked up. P501 – Dispose of contents/container to hazardous waste site.
2.3 Other hazards
Information concerning specific hazards for human and environment: see Section 11. The substance does not meet the criteria for PBT or vPvB substances according to Annex XIII of Regulation